Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE006235 |
YEM_ID: | YEM-31 |
YNS_ID: | YNS-53 |
ID: | TCMBANKHE006235/YNS-53/YEM-31 |
植物拉丁名: |
|
功能与主治: | 除风通血，消肿止痛，解毒安胎，止咳化痰。用于风盛所致的头目昏痛；风湿病肢体关节肿胀疼痛；孕期体弱多病，妊娠呕吐，月子病(产后病)出现面色苍白、心悸、胸闷、气短、头昏、头晕，形瘦体弱，咳嗽喘息，失眠多梦等；感冒咳嗽痰多，咽喉肿痛；孕期保健。/止咳祛痰。用于咳嗽，百日咳。|To clear heat and resolve toxin, relieve cough and dispel phlegm, stanch bleeding and disperse swelling./Common cold with fever, lung heat cough asthma, pertussis, icterohepatitis, stomachache, vomiting and diarrhea, malaria, swollen welling abscess and sores, painful swelling from knocks and falls, bleeding due to external injury. |
药用植物名: | 象皮木|糖胶树 |
药名: | 灯台树/灯台叶|灯台树 |
来源: | 云南药材标准：第三册/云南药材标准：第七册|云南民族药物志：第一卷 |
药用部位: | bark or leaf|干燥茎木/干燥叶 |
使用民族: | 傣族/德昂族/哈尼族/基诺族/景颇族/拉祜族/傈僳族/佤族 |
科: | 桃科 |
属: | 鸡骨常山属 |
TCM_ID_id: | 4737 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000962 | campesterol | campesterol ; FT-0082089; Augelicincampesterol; (24R)-5-Ergosten-3; (1R,3AS,3BR,9AS,9BS,11AR)-1-[(2R,5R)-5,6-DIMETHYLHEPTAN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,3AH,3BH,4H,5H,5AH,6H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-OL; A-ol; 24(R)-Ergost-5-en-3beta-ol; 24alpha-Methyl-5-cholesten-3beta-ol; AK307302; SC-66911; (8R,9S,10S,13R,14S,17R)-17-((2R,5R)-5,6-Dimethylheptan-2-yl)-10,13-dimethyl-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; AKOS027320474; MFCD00010475; Campesterin; MolPort-035-882-175 | C28H48O | 400.68 | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN001224 | lupinine | C10H19NO | 169.26 g/mol | C1CCN2CCCC(C2C1)CO | |
| TCMBANKIN001884 | echitamidine | C20H24N2O3 | 340.4 g/mol | CC(C1CN2CCC34C2CC1C(=C3NC5=CC=CC=C45)C(=O)OC)O | |
| TCMBANKIN003574 | rhazine | CC=C1CN2C3CC1C(C2CC4C3NC5=CC=CC=C45)(CO)C(=O)OC | |||
| TCMBANKIN006001 | picrinine | picri-nine | C20H22N2O3 | 338.4 g/mol | CC=C1CN2C3CC1C(C45C3(NC6=CC=CC=C64)OC2C5)C(=O)OC |
| TCMBANKIN009915 | picrasidine c | C29H26N4O4 | 494.5 g/mol | COC1=CC=CC2=C1NC3=C2C(=CN=C3CCC(C(=O)C4=NC=CC5=C4NC6=CC=CC=C56)OC)OC | |
| TCMBANKIN010249 | rheidin a | 9,9',10,10'-Tetrahydro-2',4,4',5,5'-pentahydroxy-7'-methyl-10,10'-dioxo-[9,9'-bianthracene]-2-carboxylic acid; 4,5-dihydroxy-10-oxo-9-(2,4,5-trihydroxy-7-methyl-10-oxo-9H-anthracen-9-yl)-9H-anthracene-2-carboxylic acid; 2',4,4',5,5'-PENTAHYDROXY-7'-METHYL-10,10'-DIOXO-9H,9'H-[9,9'-BIANTHRACENE]-2-CARBOXYLIC ACID; AC1NT01E; Rheidin A; 4,5-dihydroxy-10-oxo-9-(2,4,5-trihydroxy-7-methyl-10-oxo-9,10-dihydroanthracen-9-yl)-9,10-dihydroanthracene-2-carboxylic acid; Reidin A | C30H20O9 | 524.5 g/mol | CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2C4C5=C(C(=CC=C5)O)C(=O)C6=C4C=C(C=C6O)C(=O)O)C=C(C=C3O)O |
| TCMBANKIN012091 | alpha-amyrin acetate | α-amyrin acetate; alpha-Amyrin acetate | C32H52O2 | 468.75 | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC(=O)C)C)C)C2C1C)C)C |
| TCMBANKIN012636 | tetrahydroalstonine | Tetrahydroalstonine; C11682; 6474-90-4; Alstonine, 3,4,5,6-tetrahydro- (8CI); 4-27-00-07926 (Beilstein Handbook Reference); NCGC00163632-01; Prestwick1_000593; PDSP2_001642; Prestwick2_000593; SPBio_002685; NSC 72115; Alstonine, 3,4,5,6-tetrahydro; 16,17-Didehydro-19-methyloxayohimban-16-carboxylic acid, methyl ester; 4CN-0678; SCHEMBL14095094; BRN 0097270; EINECS 229-331-0; METHYL (15S,16S,20S)-16-METHYL-17-OXA-3,13-DIAZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]HENICOSA-2(10),4,6,8,18-PENTAENE-19-CARBOXYLATE; MFCD00083501; Methyl (19alpha,20alpha)-16,17-didehydro-19-methyloxayohimban-16-carboxylate; Alstonine, 3,4,5,6-tetrahydro-, (3alpha)-; AIDS-003047; Prestwick_462; CHEBI:95146; HMS1569H08; Prestwick0_000593; AKOS032948288; Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19-alpha,20-alpha)-; AIDS003047 | C21H25N2O3+ | 353.4 g/mol | CC1C2C[NH+]3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 |
| TCMBANKIN014618 | Campesteryl ferulate | campesteryl ferulate | C38H56O4 | 576.85 | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)C=CC5=CC(=C(C=C5)O)OC)C)C |
| TCMBANKIN016360 | echitamine | C22H29N2O4+ | 385.5 g/mol | CC=C1C[N+]2(CCC34C2(C(CC1C3(CO)C(=O)OC)O)NC5=CC=CC=C45)C | |
| TCMBANKIN018789 | eckol | 88798-74-7; CHEMBL471187; 1-(3,5-Dihydroxyphenoxy)-2,4,7,9-tetrahydroxydibenzo-1,4-dioxin; 4-(3,5-dihydroxyphenoxy)-dibenzo(b,e)(1,4)dioxin-1,3,6,8-tetrol; D08MZY; Dibenzo[b,e][1,4]dioxin-1,3,6,8-tetrol, 4-(3,5-dihydroxyphenoxy)-; DTXSID40237333; ZINC6091359; 4-(3,5-dihydroxyphenoxy)oxanthrene-1,3,6,8-tetrol; AC1L3S7Z; BDBM50259982; CHEBI:65819; AIDS209851; Eckol; SCHEMBL2562621; Dibenzo(b,e)(1,4)-dioxin-1,3,6,8-tetrol, 4-(3,5-dihydroxyphenoxy)-; AIDS-209851; 4-(3,5-dihydroxyphenoxy)dibenzo-p-dioxin-1,3,6,8-tetrol | C18H12O9 | 372.28 | C1=C(C=C(C=C1O)OC2=C(C=C(C3=C2OC4=C(C=C(C=C4O3)O)O)O)O)O |
| TCMBANKIN027838 | Lupeol acetate | lupeol acetate; 3-Acetyllupeol; Acetic acid (1R,3aR,4S,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-1-isopropenyl-3a,5a,5b,8,8,11a-hexamethyl-eicosahydro-cyclopenta[a]chrysen-9-yl ester; C08630; AIDS-076591; Lup-20(29)-en-3-ol, acetate, (3beta)-; LMPR01060014; AIDS076591; Lup-20(29)-en-3beta-ol, acetate (8CI); NSC 281806; 1617-68-1; EINECS 216-575-8 | C32H52O2 | 468.75 | CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)OC(=O)C)C)C |
| TCMBANKIN037078 | N4-Methyl angustilobine B | ||||
| TCMBANKIN037338 | 19,20-(e)-vallesamine | 19,20-(E)-vallesamine | C20H24N2O3 | 340.4 g/mol | CC=C1CN2CCC1C(C3=C(C2)C4=CC=CC=C4N3)(CO)C(=O)OC |
| TCMBANKIN037866 | rhazimanine | C21H26N2O3 | 354.4 g/mol | CC=C1CN2CCC3=C(C2CC1C(CO)C(=O)OC)NC4=CC=CC=C34 | |
| TCMBANKIN038707 | alpha-amyrin | α-Amyrin; C08615; Urs-12-en-3-ol; Urs-12-en-3-ol, (3beta)- (9CI); alpha-Amyrine; Urs-12-en-3.beta.-ol; ST5411384; (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol; (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-Octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-eicosahydro-picen-3-ol; (3.beta.)-Urs-12-en-3-ol; 3-epi-α-amyrin; A834570; Urs-12-en-3-ol #; FSLPMRQHCOLESF-UHFFFAOYSA-N; EINECS 211-352-1; MCULE-7089035597; 12-ursen-3beta-ol; .alpha.-Amyrine; α-amyrin; NSC-114787; alpha-Amyrin; AC1L5E7U; Urs-12-en-3beta-ol; alpha-Amyrenol; Viminalol; 638-95-9; AIDS-070313; Epi-alpha-amyrin; 53017_FLUKA; AIDS070313; AC1Q7B25; .alpha.-Amyrin; 4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol; NSC 114787; NSC114787; alpha-amyrin ; Urs-12-en-3-ol, (3.beta.)-; .alpha.-Amyrenol; LMPR01060011; α- amyrin; SMP2_000308 | C30H50O | 426.72 | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C |
| TCMBANKIN045272 | 20(S)-Tubotaiwine | 20(S)-tubotaiwine | 324.4 g/mol | ||
| TCMBANKIN048734 | angustilobine B N4-oxide | angustilobine bn4-oxide | |||
| TCMBANKIN048856 | 6,7-seco-agroclavine | C16H20N2 | 240.34 g/mol | CC(=CC1C(CC2=CNC3=CC=CC1=C23)NC)C | |
| TCMBANKIN059415 | Picralinal | C21H22N2O4 | 366.41 | CC=C1CN2C3CC1C(C45C3(NC6=CC=CC=C64)OC2C5)(C=O)C(=O)OC | |
| TCMBANKIN059704 | beta-citraurin | C30H40O2 | 432.64 g/mol | CC1=C(C(CC(C1)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=O)C)C | |
| TCMBANKIN059706 | picrocrocin | C16H26O7 | 330.37 g/mol | CC1=C(C(CC(C1)OC2C(C(C(C(O2)CO)O)O)O)(C)C)C=O | |
| TCMBANKIN060544 | alpha-amyrin | C30H50O | 426.72 g/mol | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060680 | stigmasterol-3-glucoside | C35H58O6 | 574.83 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN061312 | (+)-manilamine | C18H22N2O | 282.4 g/mol | CN1CCC(C(=CCO)C1)C(=C)C2=CC3=CC=CC=C3N2 | |
| TCMBANKIN061872 | 1-(beta-carbolin-1-yl)-4-(4,8-dimethoxy-beta-carbolin-1-yl)-2-methoxy-butan-1-one | 1-(β-carbolin-1-yl)-4-(4,8-dimethoxy-β-carbolin-1-yl)-2-methoxy-butan-1-one;picrasidine c | C29H26N4O4 | 494.5 g/mol | COC1=CC=CC2=C1NC3=C2C(=CN=C3CCC(C(=O)C4=NC=CC5=C4NC6=CC=CC=C56)OC)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab